To detect high-grade precancerious cervical lesions and cervical cancer, women ages 30 to 65 may no longer need to rely on co-testing, and can choose to either screen for high-risk human papillomavirus types or undergo cervical cytology, according to a recent draft recommendation released by the U.S. Preventive Services Task Force.
On Nov. 5, as the American people expressed their will, electing Donald Trump to a second term, I started to wonder what my friends in oncology were thinking.
